Immunothérapie cellulaire allogènique brevetée et industrialisable appelée Stimulated Tumor Cells (STC) luttant contre l’immunotolérance et la chimiorésistance.
Only investors on Gust who have been granted access can view this content.
Interested in this startup? Sign In or Sign Up to request more information.
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.
Get Started for Free